Therapeutic Agent for Corneal Diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090163432A1
SERIAL NO

12084645

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Calculated Rating
US Family Size
Non-US Coverage

Abstract

See full text

The present invention relates to a treatment agent for a disease or a disorder caused by a reduction in corneal endothelial cells, comprising as an active component at least one nucleic acid molecule inhibiting the expression of a connexin 43 gene.

First Claim

See full text

Other Claims data not available

Family

PCTEP
+

Patent Owner(s)

Patent OwnerAddress
KANSAI TECHNOLOGY LICENSING ORGANIZATION CO LTD93 CHUDOJI AWATA-CHO SHIMOGYO-KU KYOTO-SHI KYOTO

International Classification(s)

loading....
  • 2006 Application Filing Year
  • A61K Class
  • 9598 Applications Filed
  • 4848 Patents Issued To-Date
  • 50.52 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances2006200720082009201020112012201320142015201620172018201920202021202220230255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dai, Ping Kyoto , JP 24 145
Kinoshita, Shigeru Kyoto , JP 95 409
Takamatsu, Tetsuro Kyoto , JP 10 89

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 20 Citation Count
  • A61K Class
  • 64.41 % this patent is cited more than
  • 16 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges509253082135216811765452724174301 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +02004006008001000120014001600180020002200240026002800

Forward Cite Landscape

Load Citation